Fexofenadine, an orally active nonsedating H1-receptor antagonist prescribed for oral treatment of allergic rhinitis and chronic idiopathic urticaria has been shown to be a substrate of P-glycoprotein (P-gp) [9–11]. The gene discussed is PGP; the disease is chronic idiopathic urticaria.